Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 166,879 8.700% | 166,879 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 190,639 9.900% | 190,639 (New Position) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 0 0.000% | -122,948 (Position Closed) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 122,948 6.500% | -14,662 (-10.65%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL PARTNERS LP | 182,612 9.600% | 46,000 (+33.67%) | Filing History |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII, LLC | 103,650 5.500% | -10,000 (-8.80%) | Filing History |
| 2024-02-12 9:41 pm Unchanged | 2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I, L.P. | 152,921 8.100% | 0 (Unchanged) | Filing History |
| 2023-04-20 4:13 pm Purchase | 2023-04-10 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL PARTNERS LP | 136,613 7.200% | 136,613 (New Position) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 137,610 7.300% | -3,013 (-2.14%) | Filing History |
| 2023-02-13 12:36 pm Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Suvretta Capital Management, LLC | 0 0.000% | -111,513 (Position Closed) | Filing History |
| 2023-01-04 4:20 pm Sale | 2022-12-29 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 0 0.000% | -126,723 (Position Closed) | Filing History |
| 2022-12-28 2:51 pm Sale | 2022-12-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 126,723 6.700% | -58,476 (-31.57%) | Filing History |
| 2022-09-30 4:48 pm Unchanged | 2022-09-27 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 185,200 9.800% | 0 (Unchanged) | Filing History |
| 2022-07-15 4:01 pm Sale | 2022-07-13 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 185,200 9.800% | -40,000 (-17.76%) | Filing History |
| 2022-05-16 4:31 pm Sale | 2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA Capital Management, L.P. | 0 0.000% | -118,916 (Position Closed) | Filing History |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 140,622 7.500% | -6,478 (-4.40%) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT | Suvretta Capital Management, LLC | 111,513 6.000% | 111,513 (New Position) | Filing History |
| 2021-11-22 4:03 pm Unchanged | 2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 225,200 12.000% | 0 (Unchanged) | Filing History |
| 2021-08-13 5:02 pm Purchase | 2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I, L.P. | 152,921 8.400% | 58,348 (+61.70%) | Filing History |
| 2021-04-07 4:30 pm Purchase | 2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA Capital Management, L.P. | 118,916 6.500% | 118,916 (New Position) | Filing History |